SOPHiA GENETICS Reports Second Quarter 2024 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/29/2026

1. NOW
2. MSFT
3. GOOGL
4. FTNT
5. EBAY
6. CMG
7. TENB
8. KLAC
9. BIIB
10. ETSY

Go back to SOPHiA GENETICS Reports Second Quarter 2024 Results

Morgan Stanley Downgrades Sophia Genetics SA (SOPH) to Equalweight, 'Macro Weighs On Qtr/Guide'

August 7, 2024 11:31 AM EDT

Morgan Stanley analyst Tejas Savant downgraded Sophia Genetics SA (NASDAQ: SOPH) from Overweight to Equalweight with a price target of $5.00 (from $10.00).

The analyst comments "2Q miss on macro-related biopharma/EMEA headwinds; though leading indicators remain positive, guidance cut reflects achievable 2H ramp despite... More

SOPHiA GENETICS SA (SOPH) Tops Q2 EPS by 3c, Misses on Revenue; Offers FY24 Revenue Guidance

August 6, 2024 6:51 AM EDT

SOPHiA GENETICS SA (NASDAQ: SOPH) reported Q2 EPS of ($0.23), $0.03 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $16 million versus the consensus estimate of $17.4 million.

GUIDANCE:

SOPHiA GENETICS SA sees FY2024 revenue of $65-67 million, versus the... More